Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
about
Steroids for acute spinal cord injuryThe Potential of Curcumin in Treatment of Spinal Cord InjuryPotential role of stem cells in severe spinal cord injury: current perspectives and clinical dataTherapeutic approaches for spinal cord injurySpinal cord injury: a review of current therapy, future treatments, and basic science frontiersLong-Term Training with a Brain-Machine Interface-Based Gait Protocol Induces Partial Neurological Recovery in Paraplegic Patients.Critical care neurology.Early adenosine receptor activation ameliorates spinal cord reperfusion injury.Serum leptin levels following acute experimental spinal cord injury.Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trial.VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.Curiosity and cure: translational research strategies for neural repair-mediated rehabilitationPharmacological interventions for acute spinal cord injury.Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI.Antioxidant therapies in traumatic brain and spinal cord injuryAcrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injuryBasic advances and new avenues in therapy of spinal cord injuryThe spinal cord research foundation: two decades of progress.AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats.Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.Antioxidant therapies for acute spinal cord injury.Difluprednate for the prevention of ocular inflammation postsurgery: an update.The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury.Methylprednisolone for acute spinal cord injury: not a standard of careCurrent therapeutic strategies for inflammation following traumatic spinal cord injuryMelatonin lowers edema after spinal cord injury.Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in ratsSCO-spondin derived peptide NX210 induces neuroprotection in vitro and promotes fiber regrowth and functional recovery after spinal cord injurySprouting, regeneration and circuit formation in the injured spinal cord: factors and activity.Anesthetic considerations in acute spinal cord traumaAccumulation of p62 in degenerated spinal cord under chronic mechanical compression: functional analysis of p62 and autophagy in hypoxic neuronal cells.A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury.High-dose steroids for acute spinal cord injury in emergency medical services.Comparative Study on the Effects of Ceftriaxone and Monocytes on Recovery after Spinal Cord Injury in Rat.Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.Spinal cord injury without radiographic abnormality in children, 2 decades later.Setting the stage for functional repair of spinal cord injuries: a cast of thousands.Neuroprotection and acute spinal cord injury: a reappraisalDonald Munro Lecture. Spinal cord injury--past, present, and futureNeuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury
P2860
Q24203854-E84D6FF9-EA29-439A-A260-2A1112862899Q26746153-9B300D4D-1E8C-4C37-91AE-CE4F75F2A449Q26996685-BF76438D-A720-4513-8EF5-8CA5FC6C40B6Q26999949-04B32A60-CE98-4AA9-9A9B-344F5DBEA3E2Q27025166-F7958F03-DE08-4186-9B59-1325E157870FQ27323287-173623C3-AA87-43AC-AC0A-D18A1BC1A9FAQ30307728-1716F0EF-414E-4FE7-8CF1-0ED34676F4F8Q30440793-1F38665A-513E-49D5-9A07-DAD843C36CFDQ33696996-740BDF04-7892-4304-B33C-4FB2E0FDFAC1Q33842578-A41B26D7-97A9-402F-A7DE-46BC26DF8A94Q33870621-719EFC28-4F8A-4266-9C5B-3BF8989A5D09Q33904296-D0E91942-5729-47BA-B5E3-AE0923E64A69Q33909615-C27F74D3-0F99-47CA-8281-9A2C51B26867Q33914988-1C82B407-93AF-4B73-BE27-076765528687Q34049949-70447A5B-EAFE-4BFD-B2A2-9B0400DA61C3Q34096164-0E76FCEC-9E61-4AFB-98F9-D75CC145122CQ34181854-7A7FA1D6-7CED-4CAE-B22A-3FF3C04517F8Q34331920-EB0C07E4-3365-436B-828F-0DE77E03BD8DQ34355217-1C825A66-D3A8-4A99-8CDA-FB8698FFB7E0Q34368851-7C750078-5405-4E71-8C35-412FE8B16EC8Q34627821-BD33FD99-E762-47F4-888E-93F50EE096F0Q34630966-16913449-C335-4F99-B2ED-F46EE091C518Q34811137-54340177-1F3D-44F4-A6EF-DB09EE3EF515Q34963262-F775B033-48E9-4653-8FEB-65A201DBBB0DQ34997940-7C2D4CFE-4E5A-4EA2-A2CD-05015CAE0F92Q35046958-B05FDFD1-FD0B-40B7-96C1-89D86DDBE69EQ35080116-919DECDB-D88B-42B3-B525-636BE99AAFF4Q35131462-6A1E1213-6B76-4D45-8BD1-1F0803D76B46Q35172135-E25535FA-29CA-4306-BE5B-FB0BA26FEA58Q35533228-140E9441-0EF7-4564-ADC4-0C80A1E6F535Q35782367-0F7DD846-16CF-4B45-A78C-643DC5DC9005Q35831905-F4127505-C517-4812-9E54-B98F8F4C3E09Q35856466-9974287D-C64F-4599-8725-D767E6E210DAQ35895236-5665DFDE-B872-4C9F-85D7-8DC6F7B7B99FQ35964538-2866246A-125E-4BC7-AD2B-C3150C412404Q35968945-657FFBD5-F5D1-4979-BED4-D5F72B0DD2FFQ36020714-B3073363-76DB-484A-8D1D-98D4FCED2FF4Q36045235-EC4B985C-DC81-485D-BE03-F78C17BA05EBQ36076615-525CD8BC-FD13-407A-B6D4-423F9954703CQ36095115-7963CA86-F52D-42AF-97A2-8969E7CA679E
P2860
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@ast
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@en
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@nl
type
label
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@ast
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@en
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@nl
prefLabel
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@ast
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@en
Methylprednisolone or tirilaza ...... y randomized controlled trial.
@nl
P2093
P1476
Methylprednisolone or tirilaza ...... ry randomized controlled trial
@en
P2093
E F Aldrich
J E Wilberger
J Piepmeier
L F Marshall
L Leo-Summers
M B Bracken
P304
P356
10.3171/JNS.1998.89.5.0699
P577
1998-11-01T00:00:00Z